Esperion Therapeutics Inc. (NASDAQ: ESPR) completed its acquisition of Corstasis Therapeutics Inc., gaining rights to Enbumyst, a nasal spray loop ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions